Manufacturing Plants
Micro Labs is currently managing a total of 14 manufacturing plants across the country, which boasts of having state-of-the-art technology, globally certified and cGMP compliant facilities
Read MoreOur scientific advancements in API and formulation technologies are propelling curative breakthroughs in critical therapies.
Read moreExplore our comprehensive range of pharmaceutical medications, manufactured to the highest standards in cutting-edge facilities and trusted by medical professionals worldwide.
Read moree-library hosts a new age digital platform for today's medical world with a one stop digital access for hundreds of scientific presentations, specialty specific newsletters, guidelines from various therapy areas, infographics for patient education etc.
Read moreThe chronicles of Micro Labs are inextricably intertwined with the narrative of our visionary founder and luminary, Mr. G.C. Surana, whose humble origins trace back to his association with a pharmaceutical distributor in Bangalore. Leaning on his invaluable years of experience in the pharmaceutical industry and an unwavering commitment to providing affordable healthcare to all. Mr. Surana embarked on a journey to establish a pharmaceutical marketing and distribution agency catering to the southern states of India. Little did he know that his ambition back in 1973 would turn out to be a global endeavour as Micro Labs now operates as one of the leading affordable healthcare providers in India and beyond. The accreditations we have accomplished from top-notch healthcare governing bodies such as FDA-US & MHRA-UK are a testimony to the quality standards that we have been maintaining throughout our history. As we celebrate our timeless legacy, our focus is now to expand digitally into the future as India’s number one healthcare provider.
India is a true bright spot in the midst of a challenging global economy and Micro Labs has put the nation on the global pharmaceutical map. Micro Labs has a presence in over 50 countries with ground-level operations in 25 countries, with several products in most of the therapeutic segments. We are strategically poised to have a quantum leap in our global operations in the years to come.
As part of efforts to expand its footprints across African Continent, Micro Labs Limited (Micro Labs), India has acquired Swiss Pharma Nigeria Limited (Swipha), a leading pharmaceutical company in Nigeria.
Micro Labs Ltd introduces Trisopt: World’s first triple drug fixed-dose combination for Glaucoma Management.Trisopt is an indigenous development from Micro Labs, manufactured in their state-of-the-art facility located in Sikkim.
Today, Dolo-650 is the 6th largest brand (as per AWACS) in the Indian Pharmaceutical Market became the number one prescribed brand of paracetamol solid oral doses in India.
Dolo-650 gets recognized as India’s Leading Brand at the Indian Brand and Leadership Conclave 2022 organized by The Brand Story.
The company has sold 350 crore tablets since the Covid-19 outbreak in 2020, and earned revenues of Rs 400 crore in a year
Easy availability and being the doctors’ preferred prescription during the second wave.
Have you ever wondered what goes into the medicines that keep us healthy and treat our illnesses..
read moreAt Micro Labs, we understand the importance of delivering medicines that are not only effective but also safe for people to use..
read morePharmaceutical manufacturing is an essential component of the healthcare industry, responsible for producing medicines that improve and save lives..
read moreAt Micro Labs, we create stakeholder value while respecting the environment and communities. We use scientific innovation and social responsibility initiatives in education, healthcare, rural development, and environmental preservation to enhance the quality of life on our planet.- Diya Surana Head of Corporate Affairs
Micro Labs has placed India on the global pharmaceutical map, catering to regulated and emerging markets worldwide. Accredited by US FDA and UK MHRA, we strive to deliver quality and critical breakthroughs in clinical research trial facilities.- Anand Surana Director
At Micro Labs, our success has been firmly built on a portfolio of high quality drug products, regulatory compliance, trust of doctors, and a strong marketing & sales team. I am grateful to the leadership team, stakeholders, and all who have made it possible.- Dilip Surana Chairman & Managing Director